Santhera Pharmaceuticals (0QN1.LSE) Q3 2026 Earnings

21SepConfirmed
Q2 2025
Q3 2025
Q2 2026
Next
-3.03
-2.28
-1.54
-0.79

Details

Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
0
Surprise Percent
+NaN%

Description

Santhera Pharmaceuticals (0QN1.LSE) will report earnings of for Q3 2026 on September 21, 2026.

0 Comments

Share your thoughts